综述 |
|
|
|
|
基于CRISPR/Cas系统的基因编辑工具及其改进策略* |
辛圆1,田开仁3,乔建军1,2,3,财音青格乐1,2,**() |
1 天津大学化工学院 天津 300072 2 系统生物工程教育部重点实验室 天津 300072 3 天津大学浙江研究院(绍兴) 绍兴 312300 |
|
Gene Editing Tools Based on CRISPR/Cas System and Their Improvement Strategies |
XIN Yuan1,TIAN Kai-ren3,QIAO Jian-jun1,2,3,CAIYIN Qing-ge-le1,2,**() |
1 School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China 2 Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin 300072, China 3 Zhejiang Institute of Tianjin University (Shaoxing), Shaoxing 312300, China |
引用本文:
辛圆, 田开仁, 乔建军, 财音青格乐. 基于CRISPR/Cas系统的基因编辑工具及其改进策略*[J]. 中国生物工程杂志, 2023, 43(8): 72-85.
XIN Yuan, TIAN Kai-ren, QIAO Jian-jun, CAIYIN Qing-ge-le. Gene Editing Tools Based on CRISPR/Cas System and Their Improvement Strategies. China Biotechnology, 2023, 43(8): 72-85.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2303031
或
https://manu60.magtech.com.cn/biotech/CN/Y2023/V43/I8/72
|
[1] |
Koonin E V, Makarova K S, Zhang F. Diversity, classification and evolution of CRISPR-Cas systems. Current Opinion in Microbiology, 2017, 37: 67-78.
doi: S1369-5274(17)30023-1
pmid: 28605718
|
[2] |
Jamehdor S, Zaboli K A, Naserian S, et al. An overview of applications of CRISPR-Cas technologies in biomedical engineering. Folia Histochemica et Cytobiologica, 2020, 58(3): 163-173.
doi: 10.5603/FHC.a2020.0023
|
[3] |
Hille F, Richter H, Wong S P, et al. The biology of CRISPR-Cas: backward and forward. Cell, 2018, 172(6): 1239-1259.
doi: S0092-8674(17)31383-1
pmid: 29522745
|
[4] |
Jiang W Y, Bikard D, Cox D, et al. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nature Biotechnology, 2013, 31(3): 233-239.
doi: 10.1038/nbt.2508
pmid: 23360965
|
[5] |
Tao J L, Bauer D E, Chiarle R. Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing. Nature Communications, 2023, 14(1): 1-16.
doi: 10.1038/s41467-022-34464-6
|
[6] |
Komor A C, Kim Y B, Packer M S, et al. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature, 2016, 533(7603): 420-424.
doi: 10.1038/nature17946
|
[7] |
Anzalone A V, Randolph P B, Davis J R, et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature, 2019, 576(7785): 149-157.
doi: 10.1038/s41586-019-1711-4
|
[8] |
Liu G W, Lin Q P, Jin S, et al. The CRISPR-Cas toolbox and gene editing technologies. Molecular Cell, 2022, 82(2): 333-347.
doi: 10.1016/j.molcel.2021.12.002
|
[9] |
Dong C, Gou Y W, Lian J Z. SgRNA engineering for improved genome editing and expanded functional assays. Current Opinion in Biotechnology, 2022, 75: 102697.
doi: 10.1016/j.copbio.2022.102697
|
[10] |
Pyzocha N K, Chen S D. Diverse class 2 CRISPR-Cas effector proteins for genome engineering applications. ACS Chemical Biology, 2018, 13(2): 347-356.
doi: 10.1021/acschembio.7b00800
pmid: 29121460
|
[11] |
Xue C Y, Greene E C. DNA repair pathway choices in CRISPR-Cas9-mediated genome editing. Trends in Genetics, 2021, 37(7): 639-656.
doi: 10.1016/j.tig.2021.02.008
pmid: 33896583
|
[12] |
王玥, 牟彦双, 刘忠华. 基于CRISPR/Cas系统的单碱基编辑技术研究进展. 中国生物工程杂志, 2020, 40(12): 58-66.
|
|
Wang Y, Mou Y S, Liu Z H. Progress of CRISPR/Cas base editing system. China Biotechnology, 2020, 40(12): 58-66.
|
[13] |
Kurt I C, Zhou R H, Iyer S, et al. CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells. Nature Biotechnology, 2021, 39(1): 41-46.
doi: 10.1038/s41587-020-0609-x
|
[14] |
Zhao D D, Li J, Li S W, et al. Publisher Correction: Glycosylase base editors enable C-to-A and C-to-G base changes. Nature Biotechnology, 2021, 39(1): 115.
|
[15] |
Chen P J, Liu D R. Prime editing for precise and highly versatile genome manipulation. Nature Reviews Genetics, 2023, 24(3): 161-177.
doi: 10.1038/s41576-022-00541-1
|
[16] |
Manghwar H, Li B, Ding X, et al. CRISPR/Cas systems in genome editing: methodologies and tools for sgRNA design, off-target evaluation, and strategies to mitigate off-target effects. Advanced Science (Weinheim, Baden-Wurttemberg, Germany), 2020, 7(6): 1902312.
|
[17] |
Tsuchida C A, Zhang S Y, Doost M S, et al. Chimeric CRISPR-CasX enzymes and guide RNAs for improved genome editing activity. Molecular Cell, 2022, 82(6): 1199-1209.e6.
doi: 10.1016/j.molcel.2022.02.002
|
[18] |
Kim D Y, Lee J M, Bin Moon S, et al. Efficient CRISPR editing with a hypercompact Cas12f1 and engineered guide RNAs delivered by adeno-associated virus. Nature Biotechnology, 2022, 40(1): 94-102.
doi: 10.1038/s41587-021-01009-z
|
[19] |
Riesenberg S, Helmbrecht N, Kanis P, et al. Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage. Nature Communications, 2022, 13(1): 1-8.
doi: 10.1038/s41467-021-27699-2
|
[20] |
Kocak D D, Josephs E A, Bhandarkar V, et al. Increasing the specificity of CRISPR systems with engineered RNA secondary structures. Nature Biotechnology, 2019, 37(6): 657-666.
doi: 10.1038/s41587-019-0095-1
pmid: 30988504
|
[21] |
Hu Z W, Wang Y N, Liu Q, et al. Improving the precision of base editing by bubble hairpin single guide RNA. mBio, 2021, 12(2): e00342-21.
|
[22] |
Nelson J W, Randolph P B, Shen S P, et al. Engineered pegRNAs improve prime editing efficiency. Nature Biotechnology, 2022, 40(3): 402-410.
doi: 10.1038/s41587-021-01039-7
|
[23] |
Zhang G Q, Liu Y, Huang S S, et al. Enhancement of prime editing via xrRNA motif-joined pegRNA. Nature Communications, 2022, 13(1): 1-12.
doi: 10.1038/s41467-021-27699-2
|
[24] |
Li X Y, Wang X, Sun W J, et al. Enhancing prime editing efficiency by modified pegRNA with RNA G-quadruplexes. Journal of Molecular Cell Biology, 2022, 14(4): mjac022.
doi: 10.1093/jmcb/mjac022
|
[25] |
Chylinski K, Hubmann M, Hanna R E, et al. CRISPR-Switch regulates sgRNA activity by Cre recombination for sequential editing of two loci. Nature Communications, 2019, 10(1): 1-12.
doi: 10.1038/s41467-018-07882-8
|
[26] |
Carlson-Stevermer J, Kelso R, Kadina A, et al. CRISPR off enables spatio-temporal control of CRISPR editing. Nature Communications, 2020, 11(1): 1-7.
doi: 10.1038/s41467-019-13993-7
|
[27] |
Jiang Y H, Liu Y F, Wang K, et al. Fine-tuning Cas9 activity with a cognate inhibitor AcrIIA4 to improve genome editing in Streptomyces. ACS Synthetic Biology, 2021, 10(11): 2833-2841.
doi: 10.1021/acssynbio.1c00141
|
[28] |
Wang S R, Wu L Y, Huang H Y, et al. Conditional control of RNA-guided nucleic acid cleavage and gene editing. Nature Communications, 2020, 11(1): 1-10.
doi: 10.1038/s41467-019-13993-7
|
[29] |
Bao Z H, Xiao H, Liang J, et al. Homology-integrated CRISPR-Cas (HI-CRISPR) system for one-step multigene disruption in Saccharomyces cerevisiae. ACS Synthetic Biology, 2015, 4(5): 585-594.
doi: 10.1021/sb500255k
|
[30] |
Bao Z H, HamediRad M, Xue P, et al. Genome-scale engineering of Saccharomyces cerevisiae with single-nucleotide precision. Nature Biotechnology, 2018, 36(6): 505-508.
doi: 10.1038/nbt.4132
|
[31] |
Lian J Z, Schultz C, Cao M F, et al. Multi-functional genome-wide CRISPR system for high throughput genotype-phenotype mapping. Nature Communications, 2019, 10(1): 1-10.
doi: 10.1038/s41467-018-07882-8
|
[32] |
Ma X L, Zhang Q Y, Zhu Q L, et al. A robust CRISPR/Cas 9 system for convenient, high-efficiency multiplex genome editing in monocot and dicot plants. Molecular Plant, 2015, 8(8): 1274-1284.
doi: 10.1016/j.molp.2015.04.007
|
[33] |
Reis A C, Halper S M, Vezeau G E, et al. Simultaneous repression of multiple bacterial genes using nonrepetitive extra-long sgRNA arrays. Nature Biotechnology, 2019, 37(11): 1294-1301.
doi: 10.1038/s41587-019-0286-9
pmid: 31591552
|
[34] |
Xie K B, Minkenberg B, Yang Y N. Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system. Proceedings of the National Academy of Sciences of the United States of America, 2015, 112(11): 3570-3575.
|
[35] |
Zhang Y P, Wang J, Wang Z B, et al. A gRNA-tRNA array for CRISPR-Cas 9 based rapid multiplexed genome editing in Saccharomyces cerevisiae. Nature Communications, 2019, 10(1): 1-10.
doi: 10.1038/s41467-018-07882-8
|
[36] |
Haurwitz R E, Jinek M, Wiedenheft B, et al. Sequence- and structure-specific RNA processing by a CRISPR endonuclease. Science, 2010, 329(5997): 1355-1358.
doi: 10.1126/science.1192272
pmid: 20829488
|
[37] |
Tang X, Zheng X L, Qi Y P, et al. A single transcript CRISPR-Cas 9 system for efficient genome editing in plants. Molecular Plant, 2016, 9(7): 1088-1091.
doi: 10.1016/j.molp.2016.05.001
pmid: 27212389
|
[38] |
Zhang Y X, Malzahn A A, Sretenovic S, et al. The emerging and uncultivated potential of CRISPR technology in plant science. Nature Plants, 2019, 5(8): 778-794.
doi: 10.1038/s41477-019-0461-5
pmid: 31308503
|
[39] |
Filippova J, Matveeva A, Zhuravlev E, et al. Guide RNA modification as a way to improve CRISPR/Cas9-based genome-editing systems. Biochimie, 2019, 167: 49-60.
doi: S0300-9084(19)30253-6
pmid: 31493470
|
[40] |
Hendel A, Bak R O, Clark J T, et al. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nature Biotechnology, 2015, 33(9): 985-989.
doi: 10.1038/nbt.3290
pmid: 26121415
|
[41] |
Slaymaker I M, Gao L Y, Zetsche B, et al. Rationally engineered Cas 9 nucleases with improved specificity. Science, 2016, 351(6268): 84-88.
doi: 10.1126/science.aad5227
pmid: 26628643
|
[42] |
Kleinstiver B P, Pattanayak V, Prew M S, et al. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature, 2016, 529(7587): 490-495.
doi: 10.1038/nature16526
|
[43] |
Zhang H N, Kong X F, Xue M X, et al. An engineered xCas12i with high activity, high specificity, and broad PAM range. Protein & Cell, 2023, 14(7): 538-543.
|
[44] |
Chen J S, Dagdas Y S, Kleinstiver B P, et al. Enhanced proofreading governs CRISPR-Cas 9 targeting accuracy. Nature, 2017, 550(7676): 407-410.
doi: 10.1038/nature24268
|
[45] |
Sun W, Wang Y L. SuperFi-Cas9: high fidelity meets high activity. The CRISPR Journal, 2022, 5(2): 171-173.
doi: 10.1089/crispr.2022.29146.ywa
|
[46] |
Strecker J, Jones S, Koopal B, et al. Engineering of CRISPR-Cas12b for human genome editing. Nature Communications, 2019, 10(1): 1-8.
doi: 10.1038/s41467-018-07882-8
|
[47] |
Kulcsár P I, Tálas A, Huszár K, et al. Crossing enhanced and high fidelity SpCas 9 nucleases to optimize specificity and cleavage. Genome Biology, 2017, 18(1): 190.
doi: 10.1186/s13059-017-1318-8
pmid: 28985763
|
[48] |
Casini A, Olivieri M, Petris G, et al. A highly specific SpCas 9 variant is identified by in vivo screening in yeast. Nature Biotechnology, 2018, 36(3): 265-271.
doi: 10.1038/nbt.4066
|
[49] |
Lee J K, Jeong E, Lee J, et al. Directed evolution of CRISPR-Cas 9 to increase its specificity. Nature Communications, 2018, 9(1): 1-10.
doi: 10.1038/s41467-017-02088-w
|
[50] |
Vakulskas C A, Dever D P, Rettig G R, et al. A high-fidelity Cas 9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells. Nature Medicine, 2018, 24(8): 1216-1224.
doi: 10.1038/s41591-018-0137-0
|
[51] |
Schmid-Burgk J L, Gao L Y, Li D, et al. Highly parallel profiling of Cas 9 variant specificity. Molecular Cell, 2020, 78(4): 794-800.e8.
doi: S1097-2765(20)30143-X
pmid: 32187529
|
[52] |
Kleinstiver B P, Sousa A A, Walton R T, et al. Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nature Biotechnology, 2019, 37(3): 276-282.
doi: 10.1038/s41587-018-0011-0
pmid: 30742127
|
[53] |
Chen Y C, Hu Y P, Wang X G, et al. Synergistic engineering of CRISPR-Cas nucleases enables robust mammalian genome editing. Innovation (Cambridge (Mass)), 2022, 3(4): 100264.
|
[54] |
Hu J H, Miller S M, Geurts M H, et al. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature, 2018, 556(7699): 57-63.
doi: 10.1038/nature26155
|
[55] |
Miller S M, Wang T N, Randolph P B, et al. Continuous evolution of SpCas 9 variants compatible with non-G PAMs. Nature Biotechnology, 2020, 38(4): 471-481.
doi: 10.1038/s41587-020-0412-8
|
[56] |
Huang T P, Heins Z J, Miller S M, et al. High-throughput continuous evolution of compact Cas 9 variants targeting single-nucleotide-pyrimidine PAMs. Nature Biotechnology, 2023, 41(1): 96-107.
doi: 10.1038/s41587-022-01410-2
|
[57] |
Kleinstiver B P, Prew M S, Tsai S Q, et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature, 2015, 523(7561): 481-485.
doi: 10.1038/nature14592
|
[58] |
Walton R T, Christie K A, Whittaker M N, et al. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science, 2020, 368(6488): 290-296.
doi: 10.1126/science.aba8853
pmid: 32217751
|
[59] |
Esvelt K M, Mali P, Braff J L, et al. Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nature Methods, 2013, 10(11): 1116-1121.
doi: 10.1038/nmeth.2681
pmid: 24076762
|
[60] |
Müller M, Lee C M, Gasiunas G, et al. Streptococcus thermophilus CRISPR-Cas 9 systems enable specific editing of the human genome. Molecular Therapy, 2016, 24(3): 636-644.
doi: 10.1038/mt.2015.218
|
[61] |
Harrington L B, Paez-Espino D, Staahl B T, et al. A thermostable Cas 9 with increased lifetime in human plasma. Nature Communications, 2017, 8(1): 1-8.
doi: 10.1038/s41467-016-0009-6
|
[62] |
Kim E, Koo T, Park S W, et al. In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni. Nature Communications, 2017, 8(1): 1-12.
doi: 10.1038/s41467-016-0009-6
|
[63] |
Chatterjee P, Jakimo N, Lee J, et al. An engineered ScCas 9 with broad PAM range and high specificity and activity. Nature Biotechnology, 2020, 38(10): 1154-1158.
doi: 10.1038/s41587-020-0517-0
|
[64] |
Chatterjee P, Lee J, Nip L, et al. A Cas9 with PAM recognition for adenine dinucleotides. Nature Communications, 2020, 11(1): 1-6.
doi: 10.1038/s41467-019-13993-7
|
[65] |
Nishimasu H, Shi X, Ishiguro S, et al. Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science, 2018, 361(6408): 1259-1262.
doi: 10.1126/science.aas9129
pmid: 30166441
|
[66] |
Kleinstiver B P, Prew M S, Tsai S Q, et al. Broadening the targeting range of Staphylococcus aureus CRISPR-Cas 9 by modifying PAM recognition. Nature Biotechnology, 2015, 33(12): 1293-1298.
doi: 10.1038/nbt.3404
pmid: 26524662
|
[67] |
Hirano H, Gootenberg J, Horii T, et al. Structure and engineering of Francisella novicida Cas9. Cell, 2016, 164(5): 950-961.
doi: 10.1016/j.cell.2016.01.039
|
[68] |
Wu Z W, Zhang Y F, Yu H P, et al. Programmed genome editing by a miniature CRISPR-Cas12f nuclease. Nature Chemical Biology, 2021, 17(11): 1132-1138.
doi: 10.1038/s41589-021-00868-6
pmid: 34475565
|
[69] |
Liu J J, Orlova N, Oakes B L, et al. CasX enzymes comprise a distinct family of RNA-guided genome editors. Nature, 2019, 566(7743): 218-223.
doi: 10.1038/s41586-019-0908-x
|
[70] |
Harrington L B, Burstein D, Chen J S, et al. Programmed DNA destruction by miniature CRISPR-Cas14 enzymes. Science, 2018, 362(6416): 839-842.
doi: 10.1126/science.aav4294
pmid: 30337455
|
[71] |
Gao L Y, Cox D B T, Yan W X, et al. Engineered Cpf1 variants with altered PAM specificities. Nature Biotechnology, 2017, 35(8): 789-792.
doi: 10.1038/nbt.3900
pmid: 28581492
|
[72] |
Tóth E, Varga É, Kulcsár P I, et al. Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases. Nucleic Acids Research, 2020, 48(7): 3722-3733.
doi: 10.1093/nar/gkaa110
pmid: 32107556
|
[73] |
Tóth E, Czene B C, Kulcsár P I, et al. Mb- and FnCpf1 nucleases are active in mammalian cells: activities and PAM preferences of four wild-type Cpf1 nucleases and of their altered PAM specificity variants. Nucleic Acids Research, 2018, 46(19): 10272-10285.
doi: 10.1093/nar/gky815
pmid: 30239882
|
[74] |
Zhang Y X, Ren Q R, Tang X, et al. Expanding the scope of plant genome engineering with Cas12a orthologs and highly multiplexable editing systems. Nature Communications, 2021, 12(1): 1-11.
doi: 10.1038/s41467-020-20314-w
|
[75] |
Lin Q P, Zhu Z X, Liu G W, et al. Genome editing in plants with MAD7 nuclease. Journal of Genetics and Genomics, 2021, 48(6): 444-451.
doi: 10.1016/j.jgg.2021.04.003
pmid: 34120856
|
[76] |
Bertrand C, Thibessard A, Bruand C, et al. Bacterial NHEJ: a never ending story. Molecular Microbiology, 2019, 111(5): 1139-1151.
doi: 10.1111/mmi.14218
pmid: 30746801
|
[77] |
Bai Q Y, Cheng S, Zhang J L, et al. Establishment of genomic library technology mediated by non-homologous end joining mechanism in Yarrowia lipolytica. Science China Life Sciences, 2021, 64(12): 2114-2128.
doi: 10.1007/s11427-020-1885-x
|
[78] |
Zheng X, Li S Y, Zhao G P, et al. An efficient system for deletion of large DNA fragments in Escherichia coli via introduction of both Cas9 and the non-homologous end joining system from Mycobacterium smegmatis. Biochemical and Biophysical Research Communications, 2017, 485(4): 768-774.
doi: S0006-291X(17)30420-5
pmid: 28257845
|
[79] |
Cui Y L, Dong H N, Ma Y Y, et al. Strategies for applying nonhomologous end joining-mediated genome editing in prokaryotes. ACS Synthetic Biology, 2019, 8(10): 2194-2202.
doi: 10.1021/acssynbio.9b00179
pmid: 31525995
|
[80] |
Tong Y J, Charusanti P, Zhang L X, et al. CRISPR-Cas9 based engineering of actinomycetal genomes. ACS Synthetic Biology, 2015, 4(9): 1020-1029.
doi: 10.1021/acssynbio.5b00038
pmid: 25806970
|
[81] |
冯爽, 王春伟, 苏小虎. 动物基因组编辑中提升CRISPR/Cas9介导的同源重组效率研究进展. 中国生物工程杂志, 2022, 42(9): 83-92.
|
|
Feng S, Wang C W, Su X H. Research advancement of CRISPR/Cas9 directed homologous recombination efficiency improvements in mammal genome editing. China Biotechnology, 2022, 42(9): 83-92.
|
[82] |
Liu M J, Rehman S, Tang X D, et al. Methodologies for improving HDR efficiency. Frontiers in Genetics, 2019, 9: 691.
doi: 10.3389/fgene.2018.00691
|
[83] |
Kopa P, Macieja A, Pastwa E, et al. DNA double-strand breaks repair inhibitors potentiates the combined effect of VP-16 and CDDP in human colorectal adenocarcinoma (LoVo) cells. Molecular Biology Reports, 2021, 48(1): 709-720.
doi: 10.1007/s11033-020-06124-9
pmid: 33389482
|
[84] |
Yang H, Ren S L, Yu S Y, et al. Methods favoring homology-directed repair choice in response to CRISPR/Cas 9 induced-double strand breaks. International Journal of Molecular Sciences, 2020, 21(18): 6461.
doi: 10.3390/ijms21186461
|
[85] |
Reuven N, Adler J, Broennimann K, et al. Recruitment of DNA repair MRN complex by intrinsically disordered protein domain fused to Cas 9 improves efficiency of CRISPR-mediated genome editing. Biomolecules, 2019, 9(10): 584.
doi: 10.3390/biom9100584
|
[86] |
Jayavaradhan R, Pillis D M, Goodman M, et al. CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites. Nature Communications, 2019, 10(1): 1-13.
doi: 10.1038/s41467-018-07882-8
|
[87] |
Guo T T, Xin Y P, Zhang Y, et al. A rapid and versatile tool for genomic engineering in Lactococcus lactis. Microbial Cell Factories, 2019, 18(1): 1-12.
doi: 10.1186/s12934-018-1049-x
|
[88] |
Jiang Y, Chen B, Duan C L, et al. Multigene editing in the Escherichia coli genome via the CRISPR-Cas9 system. Applied and Environmental Microbiology, 2015, 81(7): 2506-2514.
doi: 10.1128/AEM.04023-14
pmid: 25636838
|
[89] |
Shy B R, Vykunta V S, Ha A, et al. High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails. Nature Biotechnology, 2023, 41(4): 521-531.
doi: 10.1038/s41587-022-01418-8
|
[90] |
Komor A C, Zhao K T, Packer M S, et al. Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C: G-to-T: a base editors with higher efficiency and product purity. Science Advances, 2017, 3(8): eaao4774.
|
[91] |
Wang L J, Xue W, Yan L, et al. Enhanced base editing by co-expression of free uracil DNA glycosylase inhibitor. Cell Research, 2017, 27(10): 1289-1292.
doi: 10.1038/cr.2017.111
pmid: 28849781
|
[92] |
Sun N X, Zhao D D, Li S W, et al. Reconstructed glycosylase base editors GBE2.0 with enhanced C-to-G base editing efficiency and purity. Molecular Therapy: the Journal of the American Society of Gene Therapy, 2022, 30(7): 2452-2463.
doi: 10.1016/j.ymthe.2022.03.023
|
[93] |
Anzalone A V, Koblan L W, Liu D R. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nature Biotechnology, 2020, 38(7): 824-844.
doi: 10.1038/s41587-020-0561-9
pmid: 32572269
|
[94] |
Richter M F, Zhao K T, Eton E, et al. Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nature Biotechnology, 2020, 38(7): 883-891.
doi: 10.1038/s41587-020-0453-z
pmid: 32433547
|
[95] |
Chen L, Zhang S, Xue N N, et al. Engineering a precise adenine base editor with minimal bystander editing. Nature Chemical Biology, 2023, 19(1): 101-110.
doi: 10.1038/s41589-022-01163-8
|
[96] |
Chen L, Zhu B Y, Ru G M, et al. Re-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editing. Nature Biotechnology, 2023, 41(5): 663-672.
doi: 10.1038/s41587-022-01532-7
|
[97] |
Koblan L W, Doman J L, Wilson C, et al. Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nature Biotechnology, 2018, 36(9): 843-846.
doi: 10.1038/nbt.4172
pmid: 29813047
|
[98] |
Kim Y B, Komor A C, Levy J M, et al. Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions. Nature Biotechnology, 2017, 35(4): 371-376.
doi: 10.1038/nbt.3803
pmid: 28191901
|
[99] |
Tan J J, Zhang F, Karcher D, et al. Engineering of high-precision base editors for site-specific single nucleotide replacement. Nature Communications, 2019, 10(1): 1-10.
doi: 10.1038/s41467-018-07882-8
|
[100] |
Anders C, Niewoehner O, Duerst A, et al. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature, 2014, 513(7519): 569-573.
doi: 10.1038/nature13579
|
[101] |
Ryu S M, Koo T, Kim K, et al. Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy. Nature Biotechnology, 2018, 36(6): 536-539.
doi: 10.1038/nbt.4148
|
[102] |
Wang Y, Liu Y, Li J W, et al. Expanding targeting scope, editing window, and base transition capability of base editing in Corynebacterium glutamicum. Biotechnology and Bioengineering, 2019, 116(11): 3016-3029.
doi: 10.1002/bit.27121
pmid: 31317533
|
[103] |
Wang Y H, Zhou L F, Liu N, et al. BE-PIGS: a base-editing tool with deaminases inlaid into Cas 9 PI domain significantly expanded the editing scope. Signal Transduction and Targeted Therapy, 2019, 4(1): 1-3.
doi: 10.1038/s41392-018-0034-5
|
[104] |
Tong H W, Wang X C, Liu Y H, et al. Programmable A-to-Y base editing by fusing an adenine base editor with an N-methylpurine DNA glycosylase. Nature Biotechnology, 2023: 1-5.
|
[105] |
Kim D Y, Chung Y, Lee Y J, et al. Hypercompact adenine base editors based on a Cas12f variant guided by engineered RNA. Nature Chemical Biology, 2022, 18(9): 1005-1013.
doi: 10.1038/s41589-022-01077-5
|
[106] |
Zong Y, Liu Y J, Xue C X, et al. Author Correction: an engineered prime editor with enhanced editing efficiency in plants. Nature Biotechnology, 2022, 40(9): 1412.
doi: 10.1038/s41587-022-01308-z
pmid: 35396351
|
[107] |
Liu P P, Liang S Q, Zheng C W, et al. Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice. Nature Communications, 2021, 12(1): 1-13.
doi: 10.1038/s41467-020-20314-w
|
[108] |
Velimirovic M, Zanetti L C, Shen M W, et al. Peptide fusion improves prime editing efficiency. Nature Communications, 2022, 13(1): 1-8.
doi: 10.1038/s41467-021-27699-2
|
[109] |
Song M, Lim J M, Min S, et al. Generation of a more efficient prime editor 2 by addition of the Rad51 DNA-binding domain. Nature Communications, 2021, 12(1): 1-8.
doi: 10.1038/s41467-020-20314-w
|
[110] |
Li M, Zhong A, Wu Y J, et al. Transient inhibition of p 53 enhances prime editing and cytosine base-editing efficiencies in human pluripotent stem cells. Nature Communications, 2022, 13(1): 1-12.
doi: 10.1038/s41467-021-27699-2
|
[111] |
Grünewald J, Miller B R, Szalay R N, et al. Engineered CRISPR prime editors with compact, untethered reverse transcriptases. Nature Biotechnology, 2023, 41(3): 337-343.
doi: 10.1038/s41587-022-01473-1
|
[112] |
Ferreira da Silva J, Oliveira G P, Arasa-Verge E A, et al. Prime editing efficiency and fidelity are enhanced in the absence of mismatch repair. Nature Communications, 2022, 13(1): 1-11.
doi: 10.1038/s41467-021-27699-2
|
[113] |
Chen P J, Hussmann J A, Yan J, et al. Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell, 2021, 184(22): 5635-5652.e29.
doi: 10.1016/j.cell.2021.09.018
pmid: 34653350
|
[114] |
Anzalone A V, Gao X D, Podracky C J, et al. Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing. Nature Biotechnology, 2022, 40(5): 731-740.
doi: 10.1038/s41587-021-01133-w
|
[115] |
Jiang T T, Zhang X O, Weng Z P, et al. Deletion and replacement of long genomic sequences using prime editing. Nature Biotechnology, 2022, 40(2): 227-234.
doi: 10.1038/s41587-021-01026-y
|
[116] |
Choi J, Chen W, Suiter C C, et al. Precise genomic deletions using paired prime editing. Nature Biotechnology, 2022, 40(2): 218-226.
doi: 10.1038/s41587-021-01025-z
|
[117] |
Yarnall M T N, Ioannidi E I, Schmitt-Ulms C, et al. Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases. Nature Biotechnology, 2023, 41(4): 500-512.
doi: 10.1038/s41587-022-01527-4
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|